Current Biomarkers in Non-Small Cell Lung Cancer—The Molecular Pathologist’s Perspective
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. Advances in tissue-based biomarkers have significantly enhanced diagnostic and therapeutic approaches in NSCLC, enabling precision medicine strategies. This review provides a comprehensive analysis of the...
Saved in:
| Main Authors: | Konrad Steinestel, Annette Arndt |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/5/631 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Profiling in Non-Small-Cell Lung Cancer: A Single-Center Study on Prevalence and Prognosis
by: Mustafa Özgür Arıcı, et al.
Published: (2025-05-01) -
Lung cancers biomarkers
by: D. A. Kharagezov, et al.
Published: (2022-03-01) -
Biomarker testing in lung cancer: from bench to bedside
by: Ullas Batra, et al.
Published: (2025-01-01) -
Next step of molecular pathology: next-generation sequencing in cytology
by: Ricella Souza da Silva, et al.
Published: (2024-11-01) -
Current Evidence Supporting the Role of miRNA as a Biomarker for Lung Cancer Diagnosis Through Exhaled Breath Condensate Collection: A Narrative Review
by: Paolo Albino Ferrari, et al.
Published: (2025-04-01)